Spontaneous Recovery of Neuromuscular Function after Atracurium in Pediatric Patients
暂无分享,去创建一个
[1] L. M. Liu,et al. Neuromuscular effects of atracurium in infants and children. , 1985, Anesthesiology.
[2] R. Matteo,et al. Distribution, Elimination, and Action of d‐Tubocurarine in Neonates, Infants, Children, and Adults , 1984, Anesthesia and analgesia.
[3] C. Coté,et al. Safety and efficacy of atracurium in adolescents and children anesthetized with halothane. , 1983, Anesthesiology.
[4] R. Miller,et al. Neuromuscular Effects of Vecuronium (ORG NC45) in Infants and Children during N2O, Halothane Anesthesia , 1983, Anesthesiology.
[5] M. Mehta,et al. Safety and Efficacy of Atracurium (BW33A) in Surgical Patients Receiving Balanced or Isoflurane Anesthesia , 1983, Anesthesiology.
[6] D. R. Cook,et al. Clinical pharmacology of atracurium in paediatric patients. , 1983, British journal of anaesthesia.
[7] H. H. Ali,et al. Clinical Pharmacology of Atracurium Besylate (BW 33A): A New Non‐depolarizing Muscle Relaxant , 1982, Anesthesia and analgesia.
[8] P. Lilleaasen,et al. Dose-response relation for atracurium, ORG NC 45 and pancuronium. , 1982, British journal of anaesthesia.
[9] E. Yodlowski,et al. Assessment of Neuromuscular Function in Infants , 1981, Anesthesiology.
[10] R. Hughes,et al. The pharmacology of atracurium: a new competitive neuromuscular blocking agent. , 1981, British journal of anaesthesia.
[11] N. Goudsouzian. Maturation of neuromuscular transmission in the infant. , 1980, British journal of anaesthesia.
[12] G. Long,et al. Neuromuscular Blockade by d‐Tubocurarine in Children , 1967, Anesthesiology.